Viatris

ISIN US92556V1061

 | 

WKN A2QAME

Market cap (in EUR)
12,439 m
Country
United States
Sector
Healthcare
Dividend yield
3.81%
 

Overview

Description

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
Show more Show less
Healthcare Biopharmaceuticals Other Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 12,439 m
EPS, EUR -2.81
P/B ratio 1.0
P/E ratio 260.7
Dividend yield 3.81%

Income statement (2024)

Revenue, EUR 13,599 m
Net income, EUR -586 m
Profit margin -4.31%

What ETF is Viatris in?

There are 20 ETFs which contain Viatris. All of these ETFs are listed in the table below. The ETF with the largest weighting of Viatris is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares STOXX USA Equity Multifactor UCITS ETF USD (Dist) 0.02%
Equity
United States
Multi-Factor Strategy
1
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Accumulating 0.01%
Equity
World
Multi-Asset Strategy
886
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
14
UBS S&P 500 Scored & Screened UCITS ETF USD dis 0.03%
Equity
United States
Social/Environmental
539
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing 0.01%
Equity
World
Multi-Asset Strategy
67
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating 0.01%
Equity
World
Multi-Asset Strategy
677
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
191
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
495
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.21%
Equity
United States
Small Cap
182
Vanguard S&P 500 UCITS ETF (USD) Distributing 0.02%
Equity
United States
43,151
Goldman Sachs ActiveBeta® Paris-Aligned Sustainable US Large Cap Equity UCITS ETF CLASS USD (Acc.) 0.54%
Equity
United States
Multi-Factor Strategy
155
Invesco Global Enhanced Equity UCITS ETF EUR PfHdg Acc 0.06%
Equity
World
Multi-Factor Strategy
0
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 1.04%
Equity
United States
Health Care
Biotech
46
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.02%
Equity
North America
Social/Environmental
27
Vanguard S&P 500 UCITS ETF (USD) Accumulating 0.02%
Equity
United States
25,892
Invesco Global Enhanced Equity UCITS ETF Acc 0.06%
Equity
World
Multi-Factor Strategy
325
iShares Core S&P 500 UCITS ETF USD (Dist) 0.02%
Equity
United States
17,558
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing 0.01%
Equity
World
Multi-Asset Strategy
88
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
34
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
87
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.